Not applicableNot Yet RecruitingNCT05980208What this trial is testingA Real-world Study of Inetetamab for First-line Treatment of MBCWho this might be right forBreast CancerReal-world Study Hunan Cancer Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00246090What this trial is testingA Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and CapecitabineWho this might be right forBreast Cancer Eisai Inc. 298
Early research (Phase 1)Study completedNCT01816035What this trial is testingTrastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by SurgeryWho this might be right forHER2/Neu PositiveRecurrent Breast CarcinomaStage IIIB Breast Cancer+2 more University of Washington 13
Testing effectiveness (Phase 2)Ended earlyNCT03435640What this trial is testingREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesWho this might be right forMelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more Nektar Therapeutics 64
Not applicableLooking for participantsNCT07638774What this trial is testingThe Efficacy of Compression/Ice Gloves/Socks in Patients With UTD1-induced Neuropathy.Who this might be right forLocally Advanced or Metastatic Breast Cancer Fudan University 324
Early research (Phase 1)Ended earlyNCT04042051What this trial is testingCopanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerWho this might be right forHER2-positive Breast CancerMetastatic Breast CancerLocally Advanced Breast Cancer+1 more Cancer Trials Ireland 2
Testing effectiveness (Phase 2)Ended earlyNCT02067741What this trial is testingCR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast CancerWho this might be right forMetastatic Breast AdenocarcinomaBreast Cancer Swiss Cancer Institute 29
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Post-approval studies (Phase 4)Study completedNCT04707196What this trial is testingAbemaciclib in Indian Women With Advanced Breast CancerWho this might be right forBreast NeoplasmsNeoplasm Metastasis Eli Lilly and Company 200
Not applicableStudy completedNCT04874025What this trial is testingObservational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast CancerWho this might be right forBreast Cancer Hospital San Carlos, Madrid 815
Testing effectiveness (Phase 2)Study completedNCT00834678What this trial is testingBendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast CancerWho this might be right forBreast Cancer Ohio State University Comprehensive Cancer Center 11
Large-scale testing (Phase 3)UnknownNCT05755048What this trial is testingFS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 314
Testing effectiveness (Phase 2)Looking for participantsNCT07100106What this trial is testingEvaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT00645333What this trial is testingPhase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer University of Michigan Rogel Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06439771What this trial is testingEvaluate the Efficacy, Safety and Pharmacokinetics of YL202 in Patients With BCWho this might be right forLocally Advanced or Metastatic Breast Cancer MediLink Therapeutics (Suzhou) Co., Ltd. 180
Early research (Phase 1)Ended earlyNCT00634088What this trial is testingPhase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerWho this might be right forLocally Advanced or Metastatic Breast Cancer R-Pharm 13
Testing effectiveness (Phase 2)Study completedNCT00301899What this trial is testingTrastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TrastuzumabWho this might be right forBreast Cancer National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Study completedNCT00626106What this trial is testingQUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerWho this might be right forBreast CancerBreast TumorsMetastatic Cancer NantCell, Inc. 156
Early research (Phase 1)Active Not RecruitingNCT03900884What this trial is testingPalbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast CancerWho this might be right forBreast Neoplasm Female Peter MacCallum Cancer Centre, Australia 17
Testing effectiveness (Phase 2)Looking for participantsNCT06042894What this trial is testingSI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast CancerWho this might be right forBreast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 58